Long term non-progressor (LTNP) HIV infection

Kumar, Praveen
September 2013
Indian Journal of Medical Research;Sep2013, Vol. 138 Issue 3, p291
Academic Journal
The article discusses long term non-progressor (LTNP) human immunodeficiency virus (HIV) infection. It offers information on the three categories of the genetic factors which influence the rate of progression from HIV to AIDS. An overview of several studies conducted on the viral factors linked to the pathogenicity of HIV-1 in humans is also presented.


Related Articles

  • Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters. Coloccini, Romina Soledad; Dilernia, Dario; Ghiglione, Yanina; Turk, Gabriela; Laufer, Natalia; Rubio, Andrea; Socías, María Eugenia; Figueroa, María Inés; Sued, Omar; Cahn, Pedro; Salomón, Horacio; Mangano, Andrea; Pando, María Ángeles // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Background: Variants in HIV-coreceptor C-C chemokine receptor type 5 (CCR5) and Human leukocyte antigen (HLA) genes are the most important host genetic factors associated with HIV infection and disease progression. Our aim was to analyze the association of these genetic factors in the presence...

  • Organizing Community Research Partnerships in the Struggle Against AIDS. Schensul, Jean J. // Health Education & Behavior;Apr99, Vol. 26 Issue 2, p266 

    Examines the history of university-community and researcher-community collaboration for AIDS research and intervention. Sociopolitical context of partnering for AIDS research; Examples of research and AIDS partnerships; Critical elements in building and sustaining university-community AIDS...

  • AIDS crisis: The end may be near, according to new report. TOWNES, GLENN // New York Amsterdam News;6/16/2011, Vol. 102 Issue 24, p33 

    The article focuses on a comprehensive study regarding the HIV/AIDS crisis conducted by the Black AIDS Institute (BAI).

  • ERRATUM.  // Journal of Infectious Diseases;Mar2011, Vol. 203 Issue 5, p749 

    A correction to the article "Class I HLA-A 7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania," that was published in the November 15, 2010 issue is presented.

  • Human immunodeficiency virus and pregnancy. Reshi, Parveen; Lone, Iqbal M. // Archives of Gynecology & Obstetrics;Sep2010, Vol. 281 Issue 5, p781 

    Management of infection with human immunodeficiency virus (HIV) dramatically improved during the 1990s. The advent of high-performance quantitative HIV assays and highly active anti-retroviral therapy (HAART) were the two most important developments in HIV medicine. As a result, HIV mortality...

  • The Pharmacogenetics of Antiretroviral Therapy: A Review of Studies to Date. Quirk, Erin; McLeod, Howard; Powderly, William // Clinical Infectious Diseases;7/1/2004, Vol. 39 Issue 1, p98 

    Although the ever-expanding armamentarium of antiretroviral drugs has significantly decreased the morbidity and mortality due to human immunodeficiency virus infection, patients and clinicians are increasingly faced with the problems of inadequate or toxic response to therapy that may be...

  • Polymorphisms in the IFNγ, IL-10, and TGFβ Genes May Be Associated with HIV-1 Infection. Bonfim Freitas, Felipe; Souza Lima, Sandra; Feitosa, Rosimar Neris Martins; Azevedo, Vânia Nakauth; Ishak, Marluísa de O. Guimarães; Ishak, Ricardo; Vallinoto, Antonio Carlos R. // Disease Markers;2/24/2015, p1 

    Objective. This study investigated possible associations between the TNFα-308G/A, IFN+874A/T, IL-6-174C/G, IL-10-1082A/G, and TGFβ-509C/T polymorphisms with HIV-1 infection, in addition to correlation of the polymorphisms with clinical markers of AIDS progression, such as levels of...

  • HIV Transgenic Mice Suggest General Kidney Fibrosis Target. Breindl, Anette // BioWorld Today;3/16/2012, Vol. 23 Issue 42, p1 

    The article focuses on a study which discovered the molecular mechanism of how HIV infection of kidney cells leads to kidney fibrosis. It has found that inhibition of HIP2 may prevent or treat not just HIV-induced kidney fibrosis but also other kinds of kidney fibrosis. Details of the...

  • The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand. Bushyakanist, Asalaysa; Puangpetch, Apichaya; Sukasem, Chonlaphat; Kiertiburanakul, Sasisopin // Pharmacogenomics & Personalized Medicine;Nov2015, Vol. 8, p163 

    Objectives: The objectives of this study were to describe the use of pharmacogenetics in clinical practice for the treatment of individuals with human immunodeficiency virus (HIV) infection and to determine the treatment outcomes of HIV-infected patients in whom pharmacogenetic testing was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics